Literature DB >> 20879887

Placebo-controlled trials in osteoporosis--proceeding with caution.

Clifford J Rosen1, Sundeep Khosla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20879887      PMCID： PMC3901575          DOI： 10.1056/NEJMsb1002227

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Ethical issues in clinical research on fracture prevention in patients with osteoporosis.

Authors:  Norman Fost
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

2.  Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Authors:  Jane A Cauley; John Robbins; Zhao Chen; Steven R Cummings; Rebecca D Jackson; Andrea Z LaCroix; Meryl LeBoff; Cora E Lewis; Joan McGowan; Joan Neuner; Mary Pettinger; Marcia L Stefanick; Jean Wactawski-Wende; Nelson B Watts
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

3.  Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF).

Authors:  Stuart L Silverman; Steven R Cummings; Nelson B Watts
Journal:  J Bone Miner Res       Date:  2008-01       Impact factor: 6.741

4.  Calcium plus vitamin D supplementation and the risk of fractures.

Authors:  Rebecca D Jackson; Andrea Z LaCroix; Margery Gass; Robert B Wallace; John Robbins; Cora E Lewis; Tamsen Bassford; Shirley A A Beresford; Henry R Black; Patricia Blanchette; Denise E Bonds; Robert L Brunner; Robert G Brzyski; Bette Caan; Jane A Cauley; Rowan T Chlebowski; Steven R Cummings; Iris Granek; Jennifer Hays; Gerardo Heiss; Susan L Hendrix; Barbara V Howard; Judith Hsia; F Allan Hubbell; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis H Kuller; Robert D Langer; Norman L Lasser; Marian C Limacher; Shari Ludlam; JoAnn E Manson; Karen L Margolis; Joan McGowan; Judith K Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Gloria E Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Evelyn Whitlock; Garnet L Anderson; Annlouise R Assaf; David Barad
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

5.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Authors:  S R Cummings; D M Black; D E Thompson; W B Applegate; E Barrett-Connor; T A Musliner; L Palermo; R Prineas; S M Rubin; J C Scott; T Vogt; R Wallace; A J Yates; A Z LaCroix
Journal:  JAMA       Date:  1998 Dec 23-30       Impact factor: 56.272

6.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Javier San Martin; Michael R McClung; Ethel S Siris; Richard Eastell; Ian R Reid; Pierre Delmas; Holly B Zoog; Matt Austin; Andrea Wang; Stepan Kutilek; Silvano Adami; Jose Zanchetta; Cesar Libanati; Suresh Siddhanti; Claus Christiansen
Journal:  N Engl J Med       Date:  2009-08-11       Impact factor: 91.245

Review 7.  The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

Authors:  J A Kanis; A Oden; O Johnell; H Johansson; C De Laet; J Brown; P Burckhardt; C Cooper; C Christiansen; S Cummings; J A Eisman; S Fujiwara; C Glüer; D Goltzman; D Hans; M-A Krieg; A La Croix; E McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; K Sanders; A-M Schott; A Silman; D Torgerson; T van Staa; N B Watts; N Yoshimura
Journal:  Osteoporos Int       Date:  2007-02-24       Impact factor: 4.507
  7 in total
  12 in total

1.  Secondary fracture prevention.

Authors:  Robert A Adler
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  Bone: Sequential osteoporosis treatment--the order of things.

Authors:  Bo Abrahamsen
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

Review 3.  Emerging therapeutic opportunities for skeletal restoration.

Authors:  Masanobu Kawai; Ulrike I Mödder; Sundeep Khosla; Clifford J Rosen
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

4.  Correlation of hip fracture with other fracture types: Toward a rational composite hip fracture endpoint.

Authors:  Cathleen Colón-Emeric; Carl F Pieper; Janet Grubber; Lynn Van Scoyoc; Merritt L Schnell; Courtney Harold Van Houtven; Megan Pearson; Joanne Lafleur; Kenneth W Lyles; Robert A Adler
Journal:  Bone       Date:  2015-07-04       Impact factor: 4.398

5.  A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.

Authors:  Erno van Schaick; Jenny Zheng; Juan Jose Perez Ruixo; Ronald Gieschke; Philippe Jacqmin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-06-30       Impact factor: 2.745

Review 6.  The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women.

Authors:  Robert B Hopkins; Ron Goeree; Eleanor Pullenayegum; Jonathan D Adachi; Alexandra Papaioannou; Feng Xie; Lehana Thabane
Journal:  BMC Musculoskelet Disord       Date:  2011-09-26       Impact factor: 2.362

Review 7.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

Review 8.  Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.

Authors:  M A Amiche; J M Albaum; M Tadrous; P Pechlivanoglou; L E Lévesque; J D Adachi; S M Cadarette
Journal:  Osteoporos Int       Date:  2016-01-18       Impact factor: 4.507

9.  Lessons learned from an osteoporosis clinical trial in frail long-term care residents.

Authors:  Sl Greenspan; D Nace; S Perera; M Ferchak; G Fiorito; D Medich; K Zukowski; D Adams; C Lee; M Saul; Nm Resnick
Journal:  Clin Trials       Date:  2011-12-07       Impact factor: 2.486

10.  Estimation of the lifetime risk of hip fracture for women and men in Canada.

Authors:  R B Hopkins; E Pullenayegum; R Goeree; J D Adachi; A Papaioannou; W D Leslie; J E Tarride; L Thabane
Journal:  Osteoporos Int       Date:  2011-05-11       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.